Pfizer in talks with India over expedited approval for Covid-19 vaccine
NEW DELHI (REUTERS) – Pfizer is in discussions with the Indian government seeking an “expedited approval pathway” for its Covid-19 vaccine, its chief executive officer Albert Bourla said on LinkedIn on Monday (May 3), announcing a donation of medicines worth more than US$70 million (S$93 million).
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he said.
“We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.”
Source: Read Full Article
